Myasthenia Gravis

MHRA approves Rozanolixizumab for myasthenia gravis patients

Science March 7, 2024

United Kingdom: The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the medicine Rozanolixizumab (Rystiggo) to treat adults with generalised…

Type above and press Enter to search. Press Esc to cancel.

Editor's Pick

Samsung workers strike for 1st time in pay dispute

Earth’s wellbeing is threatened by multiple crises; Study

COVID has not reduced humankind’s happiness around the world; Study

Myasthenia Gravis

MHRA approves Rozanolixizumab for myasthenia gravis patients

Gautam Adani faces US charges over $250 mn bribery scheme

Pizza Hut UK Operator plans fundraising to offset rising costs

NYC congestion pricing gets green light; Lowered fees set for January rollout

Apple faces legal claim over iCloud pricing and practices

‘Manifest’ takes top spot as Cambridge Dictionary’s Word of 2024

China unveils Aerospace Innovations at Zhuhai Air Show 2024

Underwater ‘Lighthouses’: China exposes spying devices targeting submarines

Wealth inequality fuels climate crisis; Oxfam Report reveals

WHO sounds alarm as Measles cases surge; Calls for renewed vaccine focus

Largest known ‘Coral’ discovered in Solomon Islands; Over 300 years old

Climate crisis intensifies as 2024 likely to be the hottest year ever

Eco-Orbit; World’s first wooden satellite launched to combat space debris

We Have

Lukashenko pardons 32 Political prisoners amid continued crackdown

Putin strengthens ties with North Korea by gifting over 70 animals

US DOJ demands Google sell Chrome to break search monopoly

Australia’s landmark social media law aims to shield kids from online harm